Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention

被引:94
|
作者
Tong, Xin [1 ]
Pelling, Jill C.
机构
[1] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA
关键词
Akt; mTOR; apigenin; cancer; CELL-CYCLE ARREST; CHEMOPREVENTIVE BIOFLAVONOID APIGENIN; CYCLOOXYGENASE-2; COX-2; EXPRESSION; SIGNAL-TRANSDUCTION PATHWAYS; GLUTATHIONE-S-TRANSFERASE; HUMAN PANCREATIC-CANCER; CYTOCHROME-C RELEASE; FLAVONOID APIGENIN; DIETARY FLAVONOIDS; TUMOR-CELLS;
D O I
10.2174/18715206113139990119
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural products are important sources of anti-cancer lead molecules, and high dietary consumption of fruits and vegetables is associated with a reduced risk of certain cancers. Many efforts have been devoted to identifying and developing plant-derived dietary constituents as chemopreventive agents. Among them, apigenin, a naturally occurring flavonoid found in a variety of fruits and leafy vegetables, has been shown to possess remarkable anti-oxidant, anti-inflammatory and anti-carcinogenic properties. This review summarizes the anti-cancer and chemopreventive effects of apigenin at cellular and molecular levels, its chemical structure and properties, with focus on mechanism related to apigenin's inhibition of the PI3K/Akt/mTOR signaling pathways.
引用
收藏
页码:971 / 978
页数:8
相关论文
共 50 条
  • [1] Targeting the PI3K/Akt/mTOR pathway for cancer prevention.
    Dennis, PA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2800S - 2801S
  • [2] Targeting PI3K/Akt/mTOR signaling in cancer
    Porta, Camillo
    Paglino, Chiara
    Mosca, Alessandra
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [3] Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma
    Blachly, James S.
    Baiocchi, Robert A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (01) : 19 - 32
  • [4] Targeting the PI3K/AKT/mTOR pathway in ovarian cancer
    Musa, Fernanda
    Schneider, Robert
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 97 - 106
  • [5] Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies
    David Barrett
    Valerie I. Brown
    Stephan A. Grupp
    David T. Teachey
    Pediatric Drugs, 2012, 14 (5) : 299 - 316
  • [6] Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies
    Barrett, David
    Brown, Valerie I.
    Grupp, Stephan A.
    Teachey, David T.
    PEDIATRIC DRUGS, 2012, 14 (05) : 299 - 316
  • [7] Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
    Li, Huayi
    Prever, Lorenzo
    Hirsch, Emilio
    Gulluni, Federico
    CANCERS, 2021, 13 (14)
  • [8] Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
    Mortazavi, Motahareh
    Moosavi, Fatemeh
    Martini, Miriam
    Giovannetti, Elisa
    Firuzi, Omidreza
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 176
  • [9] Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
    Cidado, Justin
    Park, Ben Ho
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2012, 17 (3-4) : 205 - 216
  • [10] Oncogenic Roles of the PI3K/AKT/mTOR Axis
    Aoki, Masahiro
    Fujishita, Teruaki
    VIRUSES, GENES, AND CANCER, 2017, 407 : 153 - 189